FDA MedWatch - Sure and Brut Aerosol Sprays by TCP HOT Acquisition:

Recall - Due to Presence of Benzene

If your email program has trouble displaying this email, view as a webpage. MedWatch - The FDA Safety Information and Adverse Event Reporting Program TOPIC: Sure and Brut Aerosol Sprays by TCP HOT Acquisition: Recall - Due to Presence of Benzene   AUDIENCE: Consumer, Health Professional ISSUE: TCP HOT Acquisition LLC dba HRB Brands is recalling all lot numbers with expiration dates on or before August 2023 of the Sure and Brut Aerosol Sprays due to the presence of benzene. While benzene is not an ingredient in any of the recalled products, review showed that unexpected levels of benzene came from the propellant that sprays the product out of the can. These products were owned and distributed by Helen of Troy Limited prior to June 7, 2021. Benzene is classified as a human carcinogen. Exposure to benzene can occur by inhalation, orally, and through the skin and it can result in cancers including leukemia and blood cancer of the bone marrow and blood disorders which can be life-threatening. Benzene is prevalent in the environment. Humans around the world have daily exposures to it indoors and outdoors from multiple sources. To date, no reports of adverse events related to this recall have been reported.  For more information about this recall, click on the red button "Read Recall" below. BACKGROUND: Sure and Brut Aerosol Sprays aerosol cans are used as deodorants to prevent or mask body odor or antiperspirants to reduce sweating. RECOMMENDATIONS:  Consumers should stop using the recalled products if the expiration date is on or before August 2023 and dispose of them appropriately. Consumers with questions regarding this recall can contact the company. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using these recalled products. Consumers and health professionals are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program: Complete and submit the report online. Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on form, or submit by fax to 1-800-FDA-0178.

Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA